MX2 and COVID-19: The expression of MX1, MX2, ACE2, and BSG/CD147 can cluster individuals with and without COVID-19 through principal component analysis, which indicated that the expression levels of MX1 and MX2 between patients with and without COVID-19 are remarkably different.